Brokerages Set Omnicell, Inc. (NASDAQ:OMCL) PT at $52.00

Omnicell, Inc. (NASDAQ:OMCL) has received a consensus rating of “Hold” from the six analysts that are covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $52.00.

OMCL has been the topic of several analyst reports. StockNews.com lowered Omnicell from a “buy” rating to a “hold” rating in a research note on Tuesday, December 10th. Barclays upped their price target on Omnicell from $39.00 to $58.00 and gave the company an “equal weight” rating in a research report on Thursday, October 31st. Benchmark reissued a “buy” rating and set a $48.00 price objective on shares of Omnicell in a report on Wednesday, October 9th. JPMorgan Chase & Co. upped their target price on shares of Omnicell from $37.00 to $44.00 and gave the stock a “neutral” rating in a report on Thursday, November 21st. Finally, Wells Fargo & Company increased their target price on shares of Omnicell from $30.00 to $41.00 and gave the stock an “equal weight” rating in a research report on Monday, October 14th.

Omnicell Stock Down 0.4 %

NASDAQ OMCL opened at $44.32 on Friday. Omnicell has a twelve month low of $25.12 and a twelve month high of $55.74. The stock has a market cap of $2.05 billion, a P/E ratio of -113.64, a PEG ratio of 34.96 and a beta of 0.77. The company’s 50-day simple moving average is $46.05 and its 200 day simple moving average is $40.35.

Insiders Place Their Bets

In other Omnicell news, Director Mark W. Parrish sold 12,000 shares of the company’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $47.30, for a total transaction of $567,600.00. Following the transaction, the director now owns 58,427 shares of the company’s stock, valued at approximately $2,763,597.10. This represents a 17.04 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.64% of the company’s stock.

Institutional Investors Weigh In On Omnicell

A number of institutional investors and hedge funds have recently made changes to their positions in OMCL. Louisiana State Employees Retirement System raised its holdings in Omnicell by 2.7% during the 2nd quarter. Louisiana State Employees Retirement System now owns 23,100 shares of the company’s stock worth $625,000 after purchasing an additional 600 shares during the last quarter. Panagora Asset Management Inc. boosted its position in shares of Omnicell by 1.6% in the 2nd quarter. Panagora Asset Management Inc. now owns 75,799 shares of the company’s stock worth $2,052,000 after purchasing an additional 1,204 shares during the last quarter. Rhumbline Advisers increased its holdings in Omnicell by 3.0% in the second quarter. Rhumbline Advisers now owns 147,188 shares of the company’s stock valued at $3,984,000 after purchasing an additional 4,281 shares during the last quarter. Avory & Company LLC lifted its stake in Omnicell by 3.9% in the second quarter. Avory & Company LLC now owns 250,429 shares of the company’s stock valued at $6,779,000 after buying an additional 9,466 shares during the period. Finally, Arizona State Retirement System boosted its holdings in Omnicell by 2.9% during the second quarter. Arizona State Retirement System now owns 12,853 shares of the company’s stock worth $348,000 after buying an additional 357 shares during the last quarter. Institutional investors own 97.70% of the company’s stock.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.